SCHEMBL93941

SCHEMBL93941

CCOC(=O)C(N)Cc1c[nH]cn1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.39
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
HIF1A Q16665 1/20 0.35
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TACR1 P25103 2/20 0.33
TSHR P16473 1/20 0.33
JAK2 O60674 3/20 0.32
JAK3 P52333 3/20 0.32
NLRP3 Q96P20 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CPB2 Q96IY4 1/20 0.32
GAA P10253 1/20 0.31
TPH1 P17752 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93942 1.00 SCN9A (0.39) SCN9ACYP1A2CYP2C9HIF1AKDM4E
Hydrochloric Acid SCHEMBL3069711 0.98 SCN9A (0.38) SCN9ACYP1A2CYP2C9HIF1AKDM4E
Hydrochloric Acid SCHEMBL28535122 0.98 SCN9A (0.38) SCN9ACYP1A2CYP2C9HIF1AKDM4E
Hydrochloric Acid SCHEMBL3069712 0.98 SCN9A (0.38) SCN9ACYP1A2CYP2C9HIF1AKDM4E
SCHEMBL6436196 0.88 KDM4E (0.33) SCN9AKDM4ESMN1; SMN2TSHRJAK2
SCHEMBL6436198 0.88 KDM4E (0.33) SCN9AKDM4ESMN1; SMN2TSHRJAK2
SCHEMBL262238 0.86 ALDH1A1 (0.36) ALDH1A1
SCHEMBL833709 0.86 ALDH1A1 (0.36) ALDH1A1
SCHEMBL3846863 0.86 ALDH1A1 (0.36) ALDH1A1
SCHEMBL7739707 0.86 LMNA (0.41) CYP1A2CYP2C9SMN1; SMN2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673426-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE Locus Solutions IPCO, LLC (US) 2026-01-07 EP claimed
US-20240301322-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE LOCUS SOLUTIONS IPCO LLC (US) 2024-09-12 US claimed
WO-2024182125-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE LOCUS SOLUTIONS IPCO, LLC (US) 2024-09-06 WO claimed
US-20240181394-A1 SYSTEM AND METHOD FOR RECOVERING ORGANIC ACID PRODUCTS FROM A MULTICOMPONENT FEED SOLUTION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2024-06-06 US claimed
CN-106970078-B A kind of test paper detecting o-phthalaldehyde and its preparation and detection method 北京长江脉医药科技有限责任公司 2019-10-08 CN claimed
CN-107024473-B A kind of O-phthalaldehyde disinfectant concentration quick detection test paper and the preparation method and application thereof 北京长江脉医药科技有限责任公司 2019-06-25 CN claimed
CN-107024473-A A kind of O-phthalaldehyde disinfectant concentration quick detection test paper and preparation method and application 北京长江脉医药科技有限责任公司 2017-08-08 CN claimed
CN-106970078-A A kind of test paper and its preparation and detection method for detecting OPA 北京长江脉医药科技有限责任公司 2017-07-21 CN claimed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
US-20040220264-A1 Bioavailability and improved delivery of acidic pharmaceutical drugs YU RUEY J 2004-11-04 US claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
US-20260028552-A1 Cationic Surfactants with Improved pH Stability and Their Use LOCUS SOLUTIONS IPCO LLC (US) 2026-01-29 US disclosed
EP-4673426-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE Locus Solutions IPCO, LLC (US) 2026-01-07 EP disclosed
EP-4565709-A1 CATIONIC SURFACTANTS WITH IMPROVED PH STABILITY AND THEIR USE Locus Solutions IPCO, LLC (US) 2025-06-11 EP disclosed
CN-120040435-A Mangiferin and derivatives thereof, preparation method and medical application thereof 安徽中医药大学 2025-05-27 CN disclosed
US-5106898-A Dehydrated hydrotalcite and lubricant KYOWA CHEMICAL INDUSTRY CO., LTD. (JP) 1992-04-21 US disclosed
EP-0407139-A1 Stabilizer composition for use in halogen-containing resins KYOWA CHEMICAL INDUSTRY CO., LTD. (JP) 1991-01-09 EP disclosed
CN-1047075-A Luminandide medicine MILLS RANDELL L (US) 1990-11-21 CN disclosed
EP-0359399-A1 Process for the enzymatic production of dipeptides CARLBIOTECH LTD. A/S (DK) 1990-03-21 EP disclosed
WO-1990001555-A1 A PROCESS FOR ENZYMATIC PRODUCTION OF DIPEPTIDES OR STRUCTURALLY RELATED COMPOUNDS CARLBIOTECH LTD. A/S (DK) 1990-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028552-A1 Cationic Surfactants with Improved pH Stability and Their Use CTSD, SURF4, CFD SCN9A 768/4885CYP1A2 1539/4885CYP2C9 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.